These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22111533)

  • 21. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma.
    Skrepnek GH; Skrepnek SV
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S139-52. PubMed ID: 15354679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Allergic bronchial asthma and allergic rhinitis: clinical aspects and therapy].
    Rutishauser M
    Ther Umsch; 1989 Sep; 46(9):610-8. PubMed ID: 2572071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A
    Jacobson KA; Suresh RR; Oliva P
    Int Rev Neurobiol; 2023; 170():1-27. PubMed ID: 37741687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New paradigms in purinergic receptor ligand discovery.
    Jacobson KA; Pradhan B; Wen Z; Pramanik A
    Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine receptors as promising targets for the management of ocular diseases.
    Spinozzi E; Baldassarri C; Acquaticci L; Del Bello F; Grifantini M; Cappellacci L; Riccardo P
    Med Chem Res; 2021; 30(2):353-370. PubMed ID: 33519168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the mechanism and targeted drug therapy for COPD.
    Wang C; Zhou J; Wang J; Li S; Fukunaga A; Yodoi J; Tian H
    Signal Transduct Target Ther; 2020 Oct; 5(1):248. PubMed ID: 33110061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.
    Jacobson KA; Tosh DK; Jain S; Gao ZG
    Front Cell Neurosci; 2019; 13():124. PubMed ID: 30983976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purinergic Signaling in Mast Cell Degranulation and Asthma.
    Gao ZG; Jacobson KA
    Front Pharmacol; 2017; 8():947. PubMed ID: 29311944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging pharmaceutical therapies for COPD.
    Lakshmi SP; Reddy AT; Reddy RC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2141-2156. PubMed ID: 28790817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics.
    Hothersall JD; Guo D; Sarda S; Sheppard RJ; Chen H; Keur W; Waring MJ; IJzerman AP; Hill SJ; Dale IL; Rawlins PB
    Mol Pharmacol; 2017 Jan; 91(1):25-38. PubMed ID: 27803241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration.
    Aamodt KI; Aramandla R; Brown JJ; Fiaschi-Taesch N; Wang P; Stewart AF; Brissova M; Powers AC
    Am J Physiol Endocrinol Metab; 2016 Nov; 311(5):E859-E868. PubMed ID: 27624103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of a selective and potent A2a agonist with extended lung retention.
    Åstrand AB; Lamm Bergström E; Zhang H; Börjesson L; Söderdahl T; Wingren C; Jansson AH; Smailagic A; Johansson C; Bladh H; Shamovsky I; Tunek A; Drmota T
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00134. PubMed ID: 26236482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exciting directions in glaucoma.
    Rasmussen CA; Kaufman PL
    Can J Ophthalmol; 2014 Dec; 49(6):534-43. PubMed ID: 25433744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.
    Tosh DK; Finley A; Paoletta S; Moss SM; Gao ZG; Gizewski ET; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2014 Dec; 57(23):9901-14. PubMed ID: 25422861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
    Jacobson KA
    J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement.
    Keuerleber S; Thurner P; Gruber CW; Zezula J; Freissmuth M
    J Biol Chem; 2012 Dec; 287(50):42104-18. PubMed ID: 23071116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
    Korboukh I; Hull-Ryde EA; Rittiner JE; Randhawa AS; Coleman J; Fitzpatrick BJ; Setola V; Janzen WP; Frye SV; Zylka MJ; Jin J
    J Med Chem; 2012 Jul; 55(14):6467-77. PubMed ID: 22738238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.